Patient selection for oral chemotherapy.

  title={Patient selection for oral chemotherapy.},
  author={Sheel Sharma},
  volume={15 1 Suppl 2},
Oral chemotherapy has evolved with several new agents such as capecitabine and UFT in active clinical trials or already approved for use in the western world. Several distinct issues, apart from the usual criteria for selecting patients for intravenous chemotherapy, dictate patient selection for these drugs. This article discusses these issues, which include patient preference, selection, and compliance. 

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-8 of 8 extracted citations

Effective oral chemotherapy for breast cancer: pillars of strength.

Annals of oncology : official journal of the European Society for Medical Oncology • 2008
View 5 Excerpts
Highly Influenced

A review on adherence management in patients on oral cancer therapies.

European journal of oncology nursing : the official journal of European Oncology Nursing Society • 2012
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 21 references

Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II Study

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2000
View 1 Excerpt

Intestinal physiology relevant to short-bowel syndrome.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie • 1999
View 1 Excerpt

Patient preferences for oral versus intravenous palliative chemotherapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 1997
View 1 Excerpt